ArticleFrontiers in systems neuroscience2026
Astrocytic regulation in hippocampal CA2 mediates the impact of sleep deprivation on spatial working memory.
Article in Frontiers in systems neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic sleep deprivation (CSD) is closely associated with significant mood disorders, such as anxiety and depression, and may lead to spatial memory impairment. Spatial memory is a cognitive function closely linked to the hippocampus, with the CA2 region playing a critical role in memory processing. However, the specific mechanisms by which the CA2 region contributes to spatial memory impairment induced by sleep deprivation remain unclear. This study hypothesizes that CSD impairs spatial memory by affecting the metabolic function of astrocytes in the hippocampal CA2 region. Methods: The study used 7-week-old C57BL/6J mice to establish a CSD model via the multi-platform water environment method (MPT). Functional magnetic resonance imaging (fMRI), including ALFF and ReHo analyses, was employed to assess functional changes in brain regions. Metabolic dynamics were studied using 13C-labeled glucose and sodium acetate to evaluate the metabolic states of neurons and astrocytes, respectively. Additionally, chemogenetic manipulation (via AAV viral vectors) was used to modulate the activity of astrocytes in the CA2 region, and spatial memory function was assessed through Y-maze behavioral tests. Results: CSD leads to functional abnormalities in the hippocampal CA2 region and spatial memory impairment in mice, as evidenced by increased ALFF and ReHo values in fMRI and decreased performance in the Y-maze test. Additionally, CSD induces metabolic dysregulation and calcium signaling abnormalities in CA2 astrocytes. Inhibition of calcium signaling exacerbates memory impairment, whereas activation of astrocytes can reverse this effect. Conclusion: Metabolic dysfunction and calcium signaling abnormalities in astrocytes of the hippocampal CA2 region are key mechanisms underlying spatial memory impairment caused by CSD. Activation of CA2 astrocytes can restore memory function, providing a novel therapeutic target for cognitive deficits associated with sleep disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.